Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-01-26Clinical Trial Update: Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma
This is an update on a multicenter prospective registry study of diffuse large B-cell lymphoma; the current status of the study is unknown.
-
CLINICAL_TRIALS research · 2017-01-16Clinical Trial Update: The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma [NA]
This document notes a clinical trial studying pegylated liposomal doxorubicin in combination with epirubicin for diffuse large B-cell lympho…
-
CLINICAL_TRIALS research · 2016-10-12Clinical Trial Update: Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma [NA]
This clinical trial evaluates whether liver SUVmax from 18F-FDG PET/CT can predict prognosis in patients with Diffuse large B-cell lymphoma.…
-
CLINICAL_TRIALS research · 2016-10-10Clinical Trial Update: 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma [NA]
An update on a study evaluating an 18F-FDG PET/CT-based prognostic model to predict outcomes in patients with diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS research · 2016-10-05Clinical Trial Update: Clinical and Prognostic Value of Sarcopenia in Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma [NA]
The update investigates the clinical and prognostic relevance of sarcopenia in patients over 70 with diffuse large B-cell lymphoma, highligh…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-09-07Clinical Trial Update: a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies [Phase 2]
A Phase 2 clinical trial update evaluating sequential CAR-T cell therapy followed by hematopoietic stem cell transplantation for relapse/ref…
-
CLINICAL_TRIALS research · 2016-08-03Clinical Trial Update: NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemotherapy [Phase 2]
This document provides a Phase 2 clinical trial update for NM-IL-12 (recombinant human interleukin-12) in relapsed/refractory diffuse large …
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Abbreviated R-CHOP in Completely Excised Stage I or II DLBCL [Phase 2]
A Phase 2 clinical trial update evaluating an abbreviated Rituximab-CHOP regimen in completely excised stage I/II diffuse large B-cell lymph…
-
CLINICAL_TRIALS research · 2016-07-25Clinical Trial Update: R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis [Phase 3]
Phase 3 trial comparing Rituximab-containing dose-adjusted EPOCH-21 versus a Rituximab-containing mNHL-BFM-90 program with Autologous Stem C…
-
CLINICAL_TRIALS research · 2016-07-01Clinical Trial Update: Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
This entry notes a terminated observational study at Stanford evaluating the RCHOP chemotherapy regimen with or without radiation therapy fo…
-
CLINICAL_TRIALS research · 2016-06-17Clinical Trial Update: Low-dose Radiotherapy for Diffuse Large B-cell Lymphoma [Phase 2]
A Phase 2 clinical trial update investigates low-dose radiotherapy for diffuse large B-cell lymphoma. The current status is UNKNOWN.
-
CLINICAL_TRIALS research · 2016-06-09Clinical Trial Update: Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over [Phase 2]
Phase II trial evaluating the addition of rituximab to a reduced-dose CHOP regimen in elderly patients with diffuse large B-cell lymphoma; c…
-
CLINICAL_TRIALS research · 2016-06-06Clinical Trial Update: CNS Prophylaxis in Diffuse Large B-cell Lymphoma [Phase 3]
Update on a Phase 3 trial evaluating CNS prophylaxis in diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19 [NA]
Clinical trial update describing CART19 therapy for relapsed and/or chemotherapy-refractory B-cell malignancies with an unknown status of th…
-
CLINICAL_TRIALS research · 2015-12-30Clinical Trial Update: Treatment of Diffuse Large B Cell Lymphoma [Phase 4]
Clinical trial update for a Phase 4 treatment of Diffuse Large B Cell Lymphoma. The trial status is currently unknown.
-
CLINICAL_TRIALS research · 2015-12-11Clinical Trial Update: A Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma Patients
A clinical trial update concerning improving treatment efficacy for diffuse large B-cell lymphoma; no status or results are provided in the …
-
CLINICAL_TRIALS research · 2015-11-18Clinical Trial Update: R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma [Phase 3]
This Phase 3 clinical trial compares R-CHOP with R-CDOP as first-line therapy in elderly patients with diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS research · 2015-09-29Clinical Trial Update: Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/Phase 2 study of a genetically engineered lymphocyte therapy for chemotherapy-resistant or refrac…
-
CLINICAL_TRIALS research · 2015-08-25Clinical Trial Update: High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma [Phase 3]
A Phase 3 clinical trial comparing high-dose chemotherapy with autologous stem cell transplantation to consolidating conventional chemothera…
-
CLINICAL_TRIALS research · 2013-11-21Clinical Trial Update: Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With DLBCL: a Phase II Multicenter Study of the FIL [Phase 2]
Phase II multicenter trial by Fondazione Italiana Linfomi evaluating frontline rituximab plus bendamustine in frail elderly patients over 70…
-
CLINICAL_TRIALS research · 2013-10-22Clinical Trial Update: Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients
An observational study was completed evaluating cytofluorimetric analysis of cerebrospinal fluid in patients with non-Hodgkin's lymphoma.
-
CLINICAL_TRIALS research · 2013-06-13Clinical Trial Update: Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab [NA]
This clinical trial randomized adults with diffuse large B-cell lymphoma to high-dose chemotherapy with rituximab versus CHOP-14 chemotherap…
-
CLINICAL_TRIALS research · 2013-05-30Clinical Trial Update: The Use of PET for the Early Response Evaluation in Patients With Diffuse Large B-cell Lymphoma.
This update covers a clinical trial investigating whether PET imaging can be used to evaluate early treatment response in patients with Diff…
-
CLINICAL_TRIALS research · 2013-01-17Clinical Trial Update: Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma [Phase 1]
Phase 1 trial evaluating a radiolabeled monoclonal antibody with or without peripheral stem cell transplantation in children with recurrent …
-
CLINICAL_TRIALS research · 2011-10-13Clinical Trial Update: Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating the R-COMP regimen (rituximab, cyclophosphamide, doxorubicin liposomal, vincristine, prednisone) for diffu…